Diagnosing Diabetes

To better diagnose and manage type 1 diabetes, DLS [Division of Laboratory Sciences] is using dried blood spots as matrices for field studies and developing remote monitoring technology.

Genetic Testing

DLS is researching genes involved in susceptibility and protection to type 1 diabetes through state-of-the-art molecular techniques. The genes involved in renal disease of type 1 diabetics are also being studied in detail.

Autoantibody Standardization

Samples are monitored for three crucial antibodies that the body will produce when eliciting an immune response to non-foreign cells. Early detection of these antibodies is valuable, as the patient will most likely develop type 1 diabetes if all three are detected.

Glucometer Standardization Project

CDC has more than 30 years experience in standardizing various laboratory procedures of clinical interest. DLS is now trying to develop reference materials and methods to assist manufacturers with properly calibrating portable glucose meters. 

Proteins and How They Affect Diabetics

Glycolsolation of proteins, such as hemoglobin A1c, can be detrimental to internal organs of diabetics.  Research is under way to better understand these processes so they can eventually be prevented.

New Technologies

Research and development are under way to develop an accurate and efficient, noninvasive or minimally invasive, nocturnal hypoglycemia monitor. CDC has awarded three grants totaling $700,000 for the development of these devices.